NCT05732233 (RITUAL) is a NA clinical trial of Ultivision AI in Colon Adenoma, sponsored by Satisfai Health, Inc..

Who is sponsoring NCT05732233?

NCT05732233 is sponsored by Satisfai Health, Inc..

What drugs are being tested in NCT05732233?

Interventions in NCT05732233: Ultivision AI.

What condition does NCT05732233 study?

NCT05732233 studies Colon Adenoma, Polyp of Colon, Adenoma Colon.

Is NCT05732233 still recruiting?

NCT05732233 is currently terminated. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT05732233: RITUAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RITUAL Ultivision AI CADe Randomized Controlled Trial

Terminated NA Last updated 13 May 2024

What this trial tests

NA trial testing Ultivision AI in Colon Adenoma in 137 participants. Terminated before completion.

Timeline

21 July 2023

Primary endpoint
23 February 2024

23 February 2024

Quick facts

Lead sponsor	Satisfai Health, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	137
Start date	21 July 2023
Primary completion	23 February 2024
Estimated completion	23 February 2024
Sites	4 locations across Italy, Canada, United States

Drugs / interventions tested

Ultivision AI

Conditions studied

Colon Adenoma — all drugs for Colon Adenoma →
Polyp of Colon — all drugs for Polyp of Colon →
Adenoma Colon — all drugs for Adenoma Colon →

Sponsor

Satisfai Health, Inc.

Who can join

Adults 45 to 75, any sex, with Colon Adenoma or Polyp of Colon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ultivision AI is a computer-assisted detection (CADe) device intended to aid endoscopists in the real-time identification of colonic mucosal lesions (such as polyps and adenomas). Ultivision AI CADe is indicated for white light colonoscopy only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colon Adenoma

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
NCT05041478 — Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) · NA · recruiting
NCT05355363 — Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay · NA · recruiting
NCT05402696 — St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05732233 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Satisfai Health, Inc.
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05732233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing